Health economics study estimates significant savings for England's NHS A health economic study performed by NHS England's Oxford Academic Health Science Network (AHSN) showed that Perspectum's LiverMultiScan
A first-of-its-kind study published in eClinicalMedicine - The Lancet, found that LiverMultiScan-cT1 (an MRI-derived non-invasive tissue biomarker), improved autoimmune hepatitis (AIH) management by
Perspectum announced that it has signed a strategic business partnership with Marubeni Corporation ("Marubeni") to support entry of Perspectum's AI diagnostic technology, called LiverMultiScan, into
E-Mail
IMAGE: Quantitative MR images of the liver from six patients presenting with liver cancer produced by Perspectum s LiverMultiScan which will be used in a new study led by National Cancer Centre. view more
Credit: Image credit: Mole DJ et al. Plos One. 2020;15(12):e0238568
Only 20% of primary liver cancer or hepatocellular carcinoma (HCC) are diagnosed at an early stage, which makes early detection an urgent, unmet healthcare need.
Study aims to develop more accurate diagnostics for early HCC, an AI algorithm to predict an individual s risk of developing HCC, and discover novel molecular targets to prevent the development of HCC.